Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 22:1:44.
doi: 10.1186/s40814-015-0042-y. eCollection 2015.

Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study))

Kirsty Olsen  1 , Denise Howel  2 , Robert Barber  3 , Gary A Ford  4 , Peter Gallagher  5 , R Hamish McAllister-Williams  6 , Jonna Nilsson  7 , John O'Brien  8 , Jennie Parker  9 , Alan Thomas  10
Affiliations

Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study))

Kirsty Olsen et al. Pilot Feasibility Stud. .

Abstract

Background: The blood pressure rapid intensive lowering and normal treatment for mood and cognition in persistent depression (BRILiANT mood study) was devised as a pilot study to investigate the feasibility and safety of intensive blood pressure lowering as treatment for persistent mood and cognitive symptoms in older adults with major depressive disorder and to assess the availability of this population for recruitment. In addition, the relationship between reduced blood pressure and the change in cerebral blood flow and mood was to be investigated.

Methods: A single centre pilot randomised controlled trial (RCT), with two parallel groups of intensive or normal treatment for hypertension, recruiting from primary and secondary care and newspaper advert, with an aim of recruiting 66 participants, was observed in this study. At the end of the recruitment period, in order to explore the reasons for failure to recruit to target, surveys were developed and issued to those involved in recruitment.

Results: Recruitment rates were lower than expected which led to the study being expanded to further areas and opened to self-referral via advertisement. However, because of better management of hypertension due to changes in the UK Quality and Outcomes Framework guidelines for blood pressure treatment, few eligible patients were identified and the study closed at the end of the recruitment period, with 13 participants consenting, but 12 failing screening resulting in one recruited participant.

Conclusions: Overall, the BRILiANT mood study was found not to be feasible, and results suggest that the expected patient population no longer exists. To overcome such recruitment difficulties, a prompt commencement of a study after funding so no relevant care changes occur might help prevent similar problems in future studies. In addition, self-referral, in this case via advertisement in papers, may be a useful tool to increase response rate. When recruiting in primary care, direct access to primary care databases, in a secure and anonymised way, may enable more effective screening. Ultimately, the BRILiANT mood study was shown not to be feasible; this was a useful conclusion from this pilot study.

Trial registration: ISRCTN 64524251; UKCRN Portfolio No: 13284.

Keywords: Cognitive; Depression; Hypertension; Mood; Pilot; Randomised controlled trials; Recruitment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Consort diagram showing screening and recruitment figures from primary care
Fig. 2
Fig. 2
Consort diagram showing screening and recruitment figures from secondary care
Fig. 3
Fig. 3
Consort diagram showing screening and recruitment figures from advertisements in local newspapers
See this image and copyright information in PMC

References

    1. Anderson IM, Ferrier IN, Baldwin R, Cowen PJ, Howard L, Lewis G, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2008;22:343–96. doi: 10.1177/0269881107088441. - DOI - PubMed
    1. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. Major depressive disorder: a prospective study of resudual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998;50(2-3):97–108. doi: 10.1016/S0165-0327(98)00138-4. - DOI - PubMed
    1. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17. doi: 10.1176/ajp.2006.163.11.1905. - DOI - PubMed
    1. Kennedy N, Paykel ES. Resudual symptoms at remission from depression: impact on long-term outcome. J Affect Disord. 2004;80(2-3):135–44. doi: 10.1016/S0165-0327(03)00054-5. - DOI - PubMed
    1. Kalayam BA, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry. 1999;56:713–8. doi: 10.1001/archpsyc.56.8.713. - DOI - PubMed

LinkOut - more resources